Literature DB >> 9363859

Role of the retinoblastoma protein in the pathogenesis of human cancer.

W R Sellers1, W G Kaelin.   

Abstract

The retinoblastoma gene (RB-1) was originally identified as the gene involved in hereditary retinoblastoma. However, RB-1 mutations are found in a number of common mesenchymal and epithelial malignancies. The retinoblastoma protein (pRB) acts as a transcriptional regulator of genes involved in DNA synthesis and cell-cycle control. In this regard, the functional interaction between pRB and the E2F transcription factor family appears to be critical. The pRB-E2F interaction is, in turn, regulated by a pathway that includes cyclin D1, cdk4, and p16. Mutations that affect this pathway have been documented in nearly every type of adult cancer. Thus, perturbation of pRB function may be required for the development of cancer. Insights into the biochemical functions of pRB, and its upstream regulators, may form the basis for the development of novel antineoplastic agents.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363859     DOI: 10.1200/JCO.1997.15.11.3301

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  46 in total

1.  Choosing anticancer drug targets in the postgenomic era.

Authors:  W G Kaelin
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Regulation of endogenous E2F1 stability by the retinoblastoma family proteins.

Authors:  F Martelli; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 3.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists.

Authors:  Y N Chen; S K Sharma; T M Ramsey; L Jiang; M S Martin; K Baker; P D Adams; K W Bair; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

5.  Retinoblastoma protein regulation by the COP9 signalosome.

Authors:  Zakir Ullah; Martin S Buckley; David N Arnosti; R William Henry
Journal:  Mol Biol Cell       Date:  2007-01-24       Impact factor: 4.138

6.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

7.  Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.

Authors:  M A Dickson; W C Hahn; Y Ino; V Ronfard; J Y Wu; R A Weinberg; D N Louis; F P Li; J G Rheinwald
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 8.  Cell cycle control and cancer.

Authors:  H P Wagner
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

9.  Rb and N-ras function together to control differentiation in the mouse.

Authors:  Chiaki Takahashi; Roderick T Bronson; Merav Socolovsky; Bernardo Contreras; Kwang Youl Lee; Tyler Jacks; Makoto Noda; Raju Kucherlapati; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition.

Authors:  Hasan Siddiqui; David A Solomon; Ranjaka W Gunawardena; Ying Wang; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.